Cutler Group LP Concert Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2018

May 11, 2018
SELL
$19.24 - $28.03 $5,771 - $8,409
-300 Closed
0 $0
Q4 2017

Jan 17, 2018
SELL
$13.96 - $29.05 $1,396 - $2,905
-100 Reduced 25.0%
300 $2,000
Q3 2017

Oct 17, 2017
BUY
$13.91 - $15.31 $5,564 - $6,124
400
400 $0

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email